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ABSTRACT 
The results of treatment of 25O patients with established acute 
myocardial infarction in a coronary care unit in a university 
hospital are described. The criteria for diagnosis have been 
,arefully defined. In 62 percent of patients admitted with a 
tentative diagnosis of acute infarction, the initial impression 
was confirmed. Fifteen percent of patients admitted to the unit 
were classified as having possible infarction; in this group, the 
mortality rate was 3 percent. A classification of functional 
severity based on clinical evidence of heart failure or shock is 
presented. 
Morbidity and mortality in acute myocardial infarction are 
related to the functional severity of the illness. Although 
arrhythmia is common, the overriding importance of five 
life-threatening arrhythmias is emphasized. Mortality of pa- 
~dents in the coronary care unit was not improved in comparison 
to those treated under regular care until strong cenh'al direction 
of therapeutic programs, immediate treatment of arrhythmia in 
cardiac arrest, and delegation of some medical authority to 
trained nurses was accomplished. The change in concept of the 
purposes and practices of special coronary care from resuscitation 
to prevention of arrhythmia is emphasized. 
The mortality in myocardial infarction complicated by shock 
remains high. In the absence of shock, aggressive medical 
treatment in the coronary care unit reduced mortality from 26 to 
7 percent. The implications of these data in the management of 
patients admitted to a hospital with a diagnosis of acute 
myocardial infarction are discussed. 
Originally published in the American Journal of Cardiology, October 1967, 
Revie~o 
In 1967, Killip and Kimball (1) published an article that 
helped confirm the role of the coronary care unit (CCU) as 
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an important ool in the management of patients with acute 
myocardial infarction (AMI). They asserted that the major 
benefit of  such a specialized unit is the timely recognition 
and immediate treatment of life-threatening arrhythmias. 
Most  importantly, this landmark study established a 
method for early risk stratification, or classification, of 
patients admitted to CCUs with AMI ,  eventually desig- 
50th Anniversary Historical Article 
INTRODUCTION 
In this edition of the Journal, we release the fourteenth in a 
series of reviews of influential articles that have been previously 
published in ACC journals, including the American Journal of 
Cardiology (from 1958 to 1982) and JACC (from 1983 to the 
present). The publication of these arfides is only one aspect of the 
ACC's 50th anniversary commemoration, which highlights 50 
years of leadership in cardiovascular care and education. The 
articles are intended to encourage reflection on the remarkable 
progress made in cardiovascular medicine over time, as well as to 
acknowledge the amazing prescience of some early investigators in
anticipating and, in many cases, later guiding developments in 
their field. 
The working group responsible for selecting these articles and 
asking reviewers to write editorials solicited suggestions from 
the ACC's clinical committees and indMdual members. 
The group achieved consensus fairly easily, including whom the 
group shonld ask to prepare the accompanying editorials. We 
initially drew up a list of 14 general areas to cover in this series, 
but later found that there are several major areas of modem 
cardiology, prominently molecular cardiology, in which the truly 
landmark articles have, alas, not yet been published in JACC. 
Therefore, the working roup decided not to categorize by subject, 
but instead, to concentrate on the most important articles. 
The working group, a task force of the Subcommittee for the 
Commemoration f the ACC 50th Anniversary, owes a great 
deal to Ms. May A. Roustom and the efficient and tireless taff 
at Heart House for facilitating this project. We also wish to 
thank all who suggested articles and, most important, the 
authors who prepared reviews for their willingness to contribute 
their time and wisdom. 
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nated as the the Killip classification but perhaps better 
expressed as the Killip and Kimball classification or index. 
The recognition of the importance of arrhythmias i
attributed to Samuel Levine (2), who in the 1920s was one 
of the first physicians to outline the association between 
ventricular arrhythmias and sudden death. Treatment of 
sudden cardiac arrest, however, was not described until two 
decades later, when several successful open chest resuscita- 
tions were reported. One such resuscitation described by 
Beck and colleagues (3) was of a young boy who developed 
ventricular fibrillation while undergoing surgery and was 
successfully cardioverted with electrical shock. In 1956, 
Beck (4) reported the successful cardioversion by open 
thoracotomy of a 65-year-old man with ventricular fibrilla- 
tion in the setting of myocardial infarction (MI). This 
advance was significant because it implied that patients with 
potentially fatal MIs could be resuscitated and managed 
through the crisis. Several other successful resuscitations 
were reported over the following five years (5). 
In 1960, several important advances laid the groundwork 
for the development of the CCU. These developments 
included the technique of closed chest cardiopulmonary 
resuscitation and the use of the continuous telemetry mon- 
itor with an alarm system allowing for prompt attention to 
significant arrhythmias by hospital personnel. The first 
description of the CCU was presented by Julian to the 
British Thoracic Society in 1961 (6). The response was 
positive, and monitoring of patients with AMI in special- 
ized units began in 1962. The first CCU in the U.S. was 
started by Day in Kansas, and another, not long afterward, 
by Meltzer in Philadelphia. 
In their landmark article, Killip and Kimball (1) described 
their experience with 250 patients with AMI treated in a 
specialized CCU. Patients with definite MI, as defined by 
electrocardiogram findings and laboratory enzyme results of 
SGOT, SGPT and LDH, were treated either on a regular 
ward or in a specialized CCU. Each group was subdivided 
according to severity of cardiac failure, with particular 
regard for the presence or absence of cardiogenic shock. The 
first analysis of mortality and morbidity data was set forth 
after eight months of CCU operation. One hundred pa- 
tients with definite MI treated in the CCU were compared 
with 100 patients treated in a regular ward. In the initial 
comparison, the mortality of the two groups was compara- 
ble. However, after certain decisive policy changes in the 
CCU, significant benefit was obtained. Nurses were autho- 
rized to apply precordial shock if a physician was not 
available within 60 s, and a clear protocol for treatment of 
CCU patients was given to the in-house physician by the 
senior physician. After these modifications, a significant 
improvement in mortality was observed in the next 150 
CCU patients who were not in cardiogenic shock. Most 
notably, the mortality rate decreased from 26% for patients 
treated in a regular ward to 7% for those treated in the 
CCU. In addition, patients who suffered a cardiac arrest 
were more likely to survive if the event occurred in the 
CCU. These findings confirmed the importance of the 
prompt recognition and treatment of significant arrhyth- 
mias in patients with AMI. 
Although the numbers were not large, for those patients 
in cardiogenic shock, no benefit from intensive cardiac are 
in terms of morbidity or mortality was detected. The 
mortality for these patients was quite high--69% in the 
patients managed on the regular floor and 85% for those 
treated in the CCU. The treatment ofsuch patients remains 
a considerable therapeutic challenge today. Although there 
is now evidence that the 30-day survival rate is increased in 
patients with AMI complicated by cardiogenic shock who 
undergo revascularization, the overall mortality remains 
high. It seems likely that until further treatment options 
become available for these patients, prevention of such 
complications as cardiac rupture and intractable congestive 
heart failure will be of fundamental concern in the manage- 
ment of high-risk patients with MI. 
Although Killip and Kimball (1) reported improved 
mortality and morbidity in patients with AMI treated in the 
CCU, the effectiveness of these units continued to be 
debated over the following decades. Killip and Kimball were 
not alone in reporting benefit in mortality. Others who 
directly compared patients treated in the intensive care unit 
with those treated in regular wards and found a benefit in 
terms of mortality included Meltzer (7) and Brown and 
MacMillan (8). In addition, since 1967, when the CCU 
became widely instituted in the U.S., the mortality of 
patients with AMI has decreased steadily in those older 
than 35 and those younger than 65 years of age. This 
finding, however, cannot be attributed to intensive care 
alone, as many advances have occurred simultaneously, 
including the primary and secondary prevention of athero- 
sclerotic disease and the medical and interventional man- 
agement of acute coronary syndromes. In the late 1970s, 
Hill and associates (9) compared AMI patients treated at 
home with those treated in the hospital. They found no 
significant difference in mortality for the two groups. A 
notable qualification of this study is that a significant 
subgroup of patients was excluded from the trial. These 
patients had a higher mortality than either of the other 
groups. This finding suggests that the MI was not severc 
enough in the included groups to detect a benefit from the 
management i  an acute CCU. In addition, this trial, as well 
as other similar studies, was conducted over 20 years ago, 
before vigorous techniques for controlled trials had been 
established. It now seems clear that the prevention of 
arrhythmic death in those patients who are at high risk is 
best carried out in the CCU. 
I do think, however, that there is another useful aspect of 
the article by Killip and Kimball (1)--namely, the heart 
failure (or severity) index they developed. This clinical index 
seems to have stood the test of time. It was an attempt to 
develop a bedside classification of the integrity of left 
ventricular function. Obviously it is not precise, but in large 
population studies it seems to work: there is a direct 
JACO Vol. 35, No. 5, Suppl B Fuster 51B 
April 2000:49B-S1B Myocardial infarction and CCUs 
relationship between the classification and mortality. A 
number of studies appear to have validated this index with 
respect to mortality. There is dearly something useful in the 
classification or index that Thomas Killip and John Kimball 
developed. 
It is possible that some of the less crude and more 
accurate invasive approaches used in the CCU,  such as the 
routine use of the flow-directed Swan-Ganz catheter for 
evaluation of ventricular function, may actually increase 
mortality in some cases. The use of the Swan-Ganz catheter 
in patients in intensive care units has been widely debated. 
Several retrospective studies have addressed the benefit of 
the Swan-Ganz catheter and have detected adverse out- 
comes in some patients. No prospective clinical trials have 
been undertaken to date. Some investigators have called for 
a moratorium on the use of the Swan-Ganz catheter until 
such a study is completed (10). It is possible, however, that 
because data are often made available from the pulmonary 
artery catheter, which is useful in specific clinical scenarios, 
such a moratorium would not be wise (11). Generally, use of 
the Swan-Ganz catheter should be limited to a small 
number of absolute indications in which a specific question 
is answered or by which drug therapy is guided. The most 
obvious indication for cases of AMI  would be in the 
inanagement of patients in cardiogenic shock who will be 
treated with positive inotropic intravenous agents and di- 
uretics. The length of time the catheter is left in place is also 
important. A shorter duration would be less likely to lead to 
such complications as bacteremia nd right-sided endocar- 
difis. 
This landmark article by Killip and Kimball (1) was 
important in establishing the benefit of  intensive care for 
patients with AMI .  Those patients at high risk for sudden 
death are the most likely to benefit from such specialized 
c~re. Another useful aspect of the article was the severity 
index they developed. Today it is my belief that under 
specific circumstances the use of an invasive monitoring 
device such as the Swan-Ganz catheter is important in the 
management of certain cardiac patients. However, a pro- 
spective randomized controlled trial may be useful in con- 
firming this benefit. 
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